Skip to content

Cefuroxime Sodium

FDA-approved product (injectable, injection), marketed as Cefuroxime And Dextrose In Duplex Container, Cefuroxime Sodium, Cefuroxime Sodium In Plastic Container and 4 more.

Registered studies
50+
Lab records
17
Pathogens at ≥40%
3 of 4

Chemical structure

Chemical structure of Cefuroxime Sodium
A drawing shows what the molecule is, not what it does.

Existing / approved use

Documented · FDA, WHO, ChEMBL

Approved for

  • Bacterial disease
  • Eye infection
  • Infection
  • Pneumonia

Indications ChEMBL records as approved, from FDA and DailyMed labels. Label ↗

WHO therapeutic group
Second-generation cephalosporins; Antibiotics
Anti-infective classification
Classified as an existing antimicrobial.WHO ATC J01DC02; WHO ATC S01AA27

Repurposing investigation

Cefuroxime Sodium is already an antimicrobial, so it is not counted among the repurposing candidates. Its AI-predicted activity is shown below for reference.

AI-predicted activity

AI prediction · nothing measured
  • MRSA94.2% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates. This medicine was in the model's training data, so this is recall, not a new prediction.
  • E. coli77.2% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates. This medicine was in the model's training data, so this is recall, not a new prediction.
  • K. pneumoniae20.6% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates. This medicine was in the model's training data, so this is recall, not a new prediction.
  • M. tuberculosis46.5% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.

A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.

Evidence

Clinical and experimental

Documented evidence

Clinical

50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.

Experimental

  • MRSA: measured active in 6 of 6 lab records
  • E. coli: measured active in 2 of 2 lab records
  • K. pneumoniae: measured active in 1 of 9 lab records
Show the 17 laboratory records, with sources

Loading records…

“Active” means the measured value reached this project’s laboratory cutoff (10 µM or stronger). A laboratory result does not show an effect in patients.

Docking

Computational · nothing measured

Dihydrofolate reductase ↗ (E. coli)

-6.5 kcal/mol

0better fit →-12

KPC-2 carbapenemase ↗ (K. pneumoniae)

-7.6 kcal/mol

0better fit →-12

Enoyl-ACP reductase (InhA) ↗ (M. tuberculosis)

-7.2 kcal/mol

0better fit →-12

Dihydrofolate reductase ↗ (MRSA)

-7.0 kcal/mol

0better fit →-12

AutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.

Other medicines to investigate

AI prediction · nothing measured

Other repurposing candidates: approved medicines besides Cefuroxime Sodium with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.

Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.

Registered studies

A registration describes a study; it does not establish a positive result.

  • Antibiotic Prophylaxis for Transrectal Prostate Biopsy

    NCT01659866 · start 2012-08

    Registered record
    Registry ID
    NCT01659866
    Conditions
    Infection
    Interventions
    Ciprofloxacin; trimethoprim-sulfamethoxazole; cefuroxime; ceftriaxone; gentamicin; amikacin; aztreonam; imipenem; ceftriaxone; gentamicin; amikacin; aztreonam; imipenem
    Study type
    INTERVENTIONAL
    Phase
    Phase 4
    Registry status
    Completed
    Start
    2012-08
    Completion
    2016-08
    Enrolment
    563

    As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.

    ConditionInfection
    InterventionCiprofloxacin; trimethoprim-sulfamethoxazole; cefuroxime; ceftriaxone +9 more
    PhasePhase 4
    Registry statusCompleted
  • Pharmacokinetics of Small Spectrum Beta-lactam Antibiotics (Amoxicillin/Clavulanic Acid and Cefuroxime) in Patients on Intensive Care Units

    NCT01581047 · start 2012-03-15

    Registered record
    Registry ID
    NCT01581047
    Conditions
    Infection
    Interventions
    Not recorded
    Study type
    OBSERVATIONAL
    Phase
    Not recorded
    Registry status
    Completed
    Start
    2012-03-15
    Completion
    2014-05-07
    Enrolment
    37

    As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.

    ConditionInfection
    InterventionNot recorded
    PhaseNot recorded
    Registry statusCompleted
  • Examination of the Efficacy of Preventive Antibiotic Treatment During the Puerperium Among Pregnant Women With Recurrent Urinary Tract Infections

    NCT01507974 · start 2012-01-16

    Registered record
    Registry ID
    NCT01507974
    Conditions
    Pregnancy Complications
    Interventions
    Preventive antibiotic treatment- NITROFURANTOIN; Preventive antibiotic treatment- CEPHALEXIN; PREVENTIVE TREATMENT- AMOXICILLIN; PREVENTIVE TREATMENT- AMOXICILLIN AND CLAVULANATE POTASSIUM; PREVENTIVE TREATMENT- CEFUROXIME; PREVENTIVE TREATMENT SULFAMETHOXAZOLE AND TRIMETHOPRIM
    Study type
    INTERVENTIONAL
    Phase
    Not applicable
    Registry status
    Completed
    Start
    2012-01-16
    Completion
    2015-01-01
    Enrolment
    220

    As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.

    ConditionPregnancy Complications
    InterventionPreventive antibiotic treatment- NITROFURANTOIN; Preventive antibiotic treatment- CEPHALEXIN; PREVENTIVE TREATMENT- AMOXICILLIN; PREVENTIVE TREATMENT- AMOXICILLIN AND CLAVULANATE POTASSIUM +2 more
    PhaseNot applicable
    Registry statusCompleted
  • Laparoscopic Management of Periappendicular Abscess

    NCT01283815 · start 2011-01

    Registered record
    Registry ID
    NCT01283815
    Conditions
    Appendicitis; Abdominal Abscess
    Interventions
    Laparoscopic appendectomy; Conservative management with percutaneous drainage
    Study type
    INTERVENTIONAL
    Phase
    Phase 2
    Registry status
    Completed
    Start
    2011-01
    Completion
    2014-08
    Enrolment
    60

    As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.

    ConditionAppendicitis; Abdominal Abscess
    InterventionLaparoscopic appendectomy; Conservative management with percutaneous drainage
    PhasePhase 2
    Registry statusCompleted
  • Tailored Antibiotics Prophylaxis for Percutaneous Endoscopic Gastrostomy

    NCT01237730 · start 2010-07

    Registered record
    Registry ID
    NCT01237730
    Conditions
    The Patients Who Receive Percutaneous Endoscopic Gastrostomy; Peristomal Wound Infection After the Operation of PEG; Prophylactic Antibiotics Before PEG
    Interventions
    cefuroxime; Tailored antibiotic
    Study type
    INTERVENTIONAL
    Phase
    Not applicable
    Registry status
    Unknown
    Start
    2010-07
    Completion
    2011-08
    Enrolment
    100

    As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.

    ConditionThe Patients Who Receive Percutaneous Endoscopic Gastrostomy; Peristomal Wound Infection After the Operation of PEG; Prophylactic Antibiotics Before PEG
    Interventioncefuroxime; Tailored antibiotic
    PhaseNot applicable
    Registry statusUnknown
  • Monotherapy Versus Bitherapy in Non-severe Hospitalized Community-acquired Pneumonia

    NCT00818610 · start 2009-01

    Registered record
    Registry ID
    NCT00818610
    Conditions
    Community-acquired Pneumonia
    Interventions
    Beta lactam (amoxicillin / clav. acid OR cefuroxime); Beta-lactam (amoxicillin / clav. acid OR cefuroxime) AND macrolide (clarithromycin)
    Study type
    INTERVENTIONAL
    Phase
    Phase 4
    Registry status
    Completed
    Start
    2009-01
    Completion
    2013-04
    Enrolment
    601

    As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.

    ConditionCommunity-acquired Pneumonia
    InterventionBeta lactam (amoxicillin / clav. acid OR cefuroxime); Beta-lactam (amoxicillin / clav. acid OR cefuroxime) AND macrolide (clarithromycin)
    PhasePhase 4
    Registry statusCompleted
  • The Effect of Intracameral Cefuroxime on Post-op Fibrin in Pediatric Cataract Surgery

    NCT00730938 · start 2008-02

    Registered record
    Registry ID
    NCT00730938
    Conditions
    Cataract; Endophthalmitis
    Interventions
    cefuroxime; Saline placebo
    Study type
    INTERVENTIONAL
    Phase
    Not applicable
    Registry status
    Completed
    Start
    2008-02
    Completion
    2008-08
    Enrolment
    45

    As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.

    ConditionCataract; Endophthalmitis
    Interventioncefuroxime; Saline placebo
    PhaseNot applicable
    Registry statusCompleted
  • Orally Administered Trimethoprim-sulfamethoxazole and Metronidazole as Prophylaxis of Infection Following Elective Colorectal Surgery

    NCT00613769 · start 2007-09

    Registered record
    Registry ID
    NCT00613769
    Conditions
    Infection Prophylaxis in Colo Rectal Surgery
    Interventions
    trimethoprim-sulfamethoxazole + metronidazole; cefuroxime and metronidazole
    Study type
    INTERVENTIONAL
    Phase
    Phase 4
    Registry status
    Completed
    Start
    2007-09
    Completion
    2012-05
    Enrolment
    1,073

    As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.

    ConditionInfection Prophylaxis in Colo Rectal Surgery
    Interventiontrimethoprim-sulfamethoxazole + metronidazole; cefuroxime and metronidazole
    PhasePhase 4
    Registry statusCompleted
  • Antibiotics in Free Flaps Reconstructions

    NCT02436083 · start 2007-07

    Registered record
    Registry ID
    NCT02436083
    Conditions
    Postoperative Infection
    Interventions
    antibiotic (use of penicilline, unacid, cefuroxime)
    Study type
    INTERVENTIONAL
    Phase
    Phase 4
    Registry status
    Completed
    Start
    2007-07
    Completion
    2014-12
    Enrolment
    350

    As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.

    ConditionPostoperative Infection
    Interventionantibiotic (use of penicilline, unacid, cefuroxime)
    PhasePhase 4
    Registry statusCompleted
  • Comparison of Doxycycline and Cefuroxime Axetil in Erythema Migrans

    NCT03584919 · start 2006-06-01

    Registered record
    Registry ID
    NCT03584919
    Conditions
    Erythema Chronicum Migrans
    Interventions
    doxycycline; Cefuroxime Axetil 500Mg Tab; control subjects
    Study type
    INTERVENTIONAL
    Phase
    Not applicable
    Registry status
    Completed
    Start
    2006-06-01
    Completion
    2007-09-30
    Enrolment
    509

    As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.

    ConditionErythema Chronicum Migrans
    Interventiondoxycycline; Cefuroxime Axetil 500Mg Tab; control subjects
    PhaseNot applicable
    Registry statusCompleted
  • Inflammatory Responses in Solitary and Multiple Erythema Migrans

    NCT03980015 · start 2006-06-01

    Registered record
    Registry ID
    NCT03980015
    Conditions
    Erythema Migrans
    Interventions
    antibiotic treatment
    Study type
    OBSERVATIONAL
    Phase
    Not recorded
    Registry status
    Completed
    Start
    2006-06-01
    Completion
    2019-05-31
    Enrolment
    134

    As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.

    ConditionErythema Migrans
    Interventionantibiotic treatment
    PhaseNot recorded
    Registry statusCompleted
  • Comparison of Doxycycline and Cefuroxime Axetil for Treatment of Erythema Migrans: Clinical and Microbiological Outcome

    NCT01518192 · start 2006-06

    Registered record
    Registry ID
    NCT01518192
    Conditions
    Erythema Migrans; Post-Lyme Disease Symptoms
    Interventions
    doxycycline; cefuroxime axetil
    Study type
    INTERVENTIONAL
    Phase
    Phase 4
    Registry status
    Completed
    Start
    2006-06
    Completion
    2009-01
    Enrolment
    544

    As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.

    ConditionErythema Migrans; Post-Lyme Disease Symptoms
    Interventiondoxycycline; cefuroxime axetil
    PhasePhase 4
    Registry statusCompleted
  • Do Corticosteroid Injections During Total Knee Replacement Improve Early Clinical Results?

    NCT00492973 · start 2006-03

    Registered record
    Registry ID
    NCT00492973
    Conditions
    Osteoarthritis; Post-traumatic; Arthrosis
    Interventions
    methylprednisolone acetate; active comparator
    Study type
    INTERVENTIONAL
    Phase
    Not applicable
    Registry status
    Completed
    Start
    2006-03
    Completion
    2008-02
    Enrolment
    101

    As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.

    ConditionOsteoarthritis; Post-traumatic; Arthrosis
    Interventionmethylprednisolone acetate; active comparator
    PhaseNot applicable
    Registry statusCompleted
  • Ampicillin/Sulbactam Versus Cefuroxime as Antimicrobial Prophylaxis for Cesarean Section

    NCT01138852 · start 2004-07

    Registered record
    Registry ID
    NCT01138852
    Conditions
    Surgical Site Infections
    Interventions
    Ampicillin-sulbactam; Cefuroxime
    Study type
    INTERVENTIONAL
    Phase
    Phase 4
    Registry status
    Completed
    Start
    2004-07
    Completion
    2008-12
    Enrolment
    176

    As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.

    ConditionSurgical Site Infections
    InterventionAmpicillin-sulbactam; Cefuroxime
    PhasePhase 4
    Registry statusCompleted
  • PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis

    NCT00132938 · start 2004-01

    Registered record
    Registry ID
    NCT00132938
    Conditions
    Chronic Bronchitis
    Interventions
    telithromycin
    Study type
    INTERVENTIONAL
    Phase
    Phase 4
    Registry status
    Completed
    Start
    2004-01
    Completion
    2006-05
    Enrolment
    5,660

    As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.

    ConditionChronic Bronchitis
    Interventiontelithromycin
    PhasePhase 4
    Registry statusCompleted